Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 1
1998 1
2016 2
2017 5
2019 2
2020 5
2021 1
2022 2
2023 1
2024 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer-a prospective national multicentre study (EMIT-1).
Ohnstad HO, Blix ES, Akslen LA, Gilje B, Raj SX, Skjerven H, Borgen E, Janssen EAM, Mortensen E, Brekke MB, Falk RS, Schlichting E, Boge B, Songe-Møller S, Olsson P, Heie A, Mannsåker B, Vestlid MA, Kursetgjerde T, Gravdehaug B, Suhrke P, Sanchez E, Bublevic J, Røe OD, Geitvik GA, Halset EH, Rypdal MC, Langerød A, Lømo J, Garred Ø, Porojnicu A, Engebraaten O, Geisler J, Lyngra M, Hansen MH, Søiland H, Nakken T, Asphaug L, Kristensen V, Sørlie T, Nygård JF, Kiserud CE, Reinertsen KV, Russnes HG, Naume B. Ohnstad HO, et al. Among authors: geitvik ga. ESMO Open. 2024 Jun;9(6):103475. doi: 10.1016/j.esmoop.2024.103475. Epub 2024 Jun 4. ESMO Open. 2024. PMID: 38838499 Free PMC article.
Breast cancer quantitative proteome and proteogenomic landscape.
Johansson HJ, Socciarelli F, Vacanti NM, Haugen MH, Zhu Y, Siavelis I, Fernandez-Woodbridge A, Aure MR, Sennblad B, Vesterlund M, Branca RM, Orre LM, Huss M, Fredlund E, Beraki E, Garred Ø, Boekel J, Sauer T, Zhao W, Nord S, Höglander EK, Jans DC, Brismar H, Haukaas TH, Bathen TF, Schlichting E, Naume B; Consortia Oslo Breast Cancer Research Consortium (OSBREAC); Luders T, Borgen E, Kristensen VN, Russnes HG, Lingjærde OC, Mills GB, Sahlberg KK, Børresen-Dale AL, Lehtiö J. Johansson HJ, et al. Nat Commun. 2019 Apr 8;10(1):1600. doi: 10.1038/s41467-019-09018-y. Nat Commun. 2019. PMID: 30962452 Free PMC article.
Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer - the MetAction study.
Ree AH, Nygaard V, Boye K, Heinrich D, Dueland S, Bergheim IR, Johansen C, Beiske K, Negård A, Lund-Iversen M, Nygaard V, Hovig E, Nakken S, Nasser S, Julsrud L, Reisse CH, Ruud EA, Kristensen VN, Flørenes VA, Geitvik GA, Lingjærde OC, Børresen-Dale AL, Russnes HG, Mælandsmo GM, Flatmark K. Ree AH, et al. Among authors: geitvik ga. Acta Oncol. 2020 Jul;59(7):733-740. doi: 10.1080/0284186X.2020.1742377. Epub 2020 Mar 25. Acta Oncol. 2020. PMID: 32208873 Free article.
Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate.
Ree AH, Russnes HG, Heinrich D, Dueland S, Boye K, Nygaard V, Silwal-Pandit L, Østrup O, Hovig E, Nygaard V, Rødland EA, Nakken S, Øien JT, Johansen C, Bergheim IR, Skarpeteig V, Sathermugathevan M, Sauer T, Lund-Iversen M, Beiske K, Nasser S, Julsrud L, Reisse CH, Ruud EA, Flørenes VA, Hagene KT, Aas E, Lurås H, Johnsen-Soriano S, Geitvik GA, Lingjærde OC, Børresen-Dale AL, Mælandsmo GM, Flatmark K. Ree AH, et al. Among authors: geitvik ga. ESMO Open. 2017 May 2;2(2):e000158. doi: 10.1136/esmoopen-2017-000158. eCollection 2017. ESMO Open. 2017. PMID: 28761742 Free PMC article.
[The polyposis project].
Gedde-Dahl T Jr, Heim S, Lothe R, Bye R, Geitvik GA, Kyrkjebø HT, Hognestad J, Nygaard K, Bergan A, Olaisen B, et al. Gedde-Dahl T Jr, et al. Among authors: geitvik ga. Nord Med. 1989;104(1):12-5. Nord Med. 1989. PMID: 2536147 Norwegian.
Cost-effectiveness of Prosigna for Adjuvant Treatment Decisions in Early Breast Cancer: Healthcare Sector and Societal Perspectives.
Asphaug L, Akslen LA, Blix ES, Boge B, Borgen EF, Brekke MB, Falk RS, Geitvik GA, Gilje B, Gravdehaug B, Heie A, Janssen E, Kiserud CE, Kursetgjerde T, Langerød A, Lømo J, Mannsåker B, Mortensen E, Olsson P, Porojnicu AC, Raj SX, Roe OD, Russnes HEG, Skjerven HK, Songe-Møller S, Vestlid MA, Ohnstad HO, Naume B. Asphaug L, et al. Among authors: geitvik ga. Clin Breast Cancer. 2025 Aug;25(6):e721-e730. doi: 10.1016/j.clbc.2025.04.011. Epub 2025 Apr 15. Clin Breast Cancer. 2025. PMID: 40348620 Free article.
Deep learning for automated scoring of immunohistochemically stained tumour tissue sections - Validation across tumour types based on patient outcomes.
Kildal W, Cyll K, Kalsnes J, Islam R, Julbø FM, Pradhan M, Ersvær E, Shepherd N, Vlatkovic L; OSBREAC; Tekpli X, Garred Ø, Kristensen GB, Askautrud HA, Hveem TS, Danielsen HE; OSBREAC - Oslo Breast Cancer Consortium. Kildal W, et al. Heliyon. 2024 Jun 13;10(13):e32529. doi: 10.1016/j.heliyon.2024.e32529. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39040241 Free PMC article.
[The polyposis project].
Gedde-Dahl T Jr, Heim S, Lothe R, Bye R, Brevik K, Geitvik GA, Kyrkjebø HT, Hognestad J, Nygaard K, Bergan A, et al. Gedde-Dahl T Jr, et al. Among authors: geitvik ga. Tidsskr Nor Laegeforen. 1988 Oct 20;108(29):2465-8. Tidsskr Nor Laegeforen. 1988. PMID: 2905084 Norwegian. No abstract available.
27 results